BODi Bets on GLP-1 Support and 10-Minute Workouts
Digital fitness platforms are facing a question they didn't anticipate a few years ago: how do you serve a user who's losing weight rapidly, at risk of losing muscle along with it, and barely has the energy or motivation to exercise? BODi, the streaming fitness brand formerly known as Beachbody, has an answer. It's building out a catalog of ultra-short workouts explicitly designed to work alongside GLP-1 medications. And the strategy says a lot about where the fitness industry is heading.
Three New Programs, One Clear Signal
BODi recently announced the addition of three new programs to its 10 Minute BODi catalog. The programs focus on longevity, metabolic health, and functional movement. Each one is structured around short daily sessions that can be completed without equipment, in limited space, and at varying energy levels.
That last point matters more than it might seem. GLP-1 medications like semaglutide and tirzepatide suppress appetite significantly, which often leads to reduced caloric intake and, with it, lower energy levels. For many users, the idea of a 45-minute high-intensity session becomes genuinely unappealing. A 10-minute routine doesn't.
BODi is leaning into that reality rather than pretending it doesn't exist. The new programs are framed openly as companions to GLP-1 use, not just general fitness content that happens to be short. That's a notable shift in how a major digital fitness brand is positioning its product.
Why GLP-1 Users Need a Different Kind of Workout
The core concern for anyone using GLP-1 medications isn't weight loss. That part is largely handled by the drug. The concern is what you're losing. Research consistently shows that without deliberate resistance training, a significant portion of weight lost on GLP-1 medications comes from lean muscle mass rather than fat alone. Some estimates put muscle loss at 25 to 40 percent of total weight lost when no structured exercise is involved.
That's a real problem. Muscle mass is tied to metabolic rate, functional independence, bone density, and long-term health outcomes. If you're losing it while the scale drops, you may look lighter but be metabolically worse off than before. For a deeper breakdown of this issue, GLP-1 and Muscle Loss: How to Keep Your Gains covers what the research says and what you can actually do about it.
This is where resistance-focused, low-barrier exercise becomes critical. It doesn't need to be intense. It needs to be consistent and targeted. BODi's 10-minute format is a direct response to that prescription.
The Longevity and Metabolic Health Angle
Two of the three new programs specifically target longevity and metabolic health, areas that have surged in consumer interest alongside the GLP-1 wave. This isn't accidental positioning. The demographic taking GLP-1 medications skews toward people in their 40s, 50s, and beyond, many of whom are managing metabolic conditions like type 2 diabetes or obesity-related cardiovascular risk.
For that audience, the fitness conversation is less about aesthetics and more about function and longevity. Research published in major cardiovascular journals has linked cardiorespiratory fitness to mortality risk more strongly than body weight alone. As your cardio fitness level predicts lifespan better than you think, maintaining physical capacity while losing weight becomes a non-negotiable goal rather than a bonus.
BODi's framing of these programs around metabolic and longevity outcomes positions the brand alongside medical weight management rather than in competition with it. That's a smart play in a market where fitness and healthcare are converging faster than most platforms have been willing to acknowledge.
Short Workouts Are Not a Compromise
There's a persistent assumption in fitness culture that shorter means lesser. If you're only doing 10 minutes, you're not really working out. That assumption doesn't hold up to scrutiny.
For people building consistency from scratch, or returning to exercise after a long gap, shorter sessions dramatically lower the psychological barrier to entry. The hardest part of any workout is starting. A 10-minute commitment is far easier to honor than a 45-minute one, and completing it daily builds the behavioral pattern that longer programs often fail to establish.
Beyond the behavioral argument, the physiological case for brief training is stronger than most people expect. Brief intense workouts deliver real health benefits, particularly for metabolic markers and cardiovascular function, even when total volume is modest. For GLP-1 users operating on reduced energy, this matters.
The muscle preservation goal doesn't require marathon sessions either. Targeted resistance work performed consistently, even in short blocks, is sufficient to signal muscle retention. That's the mechanism BODi is trying to tap.
Digital Fitness Brands Are Repositioning
BODi isn't the only platform sensing a shift. Across the digital fitness industry, there's a quiet recalibration happening. The traditional model, built around high-energy, high-volume programs designed to produce dramatic body transformation, is being supplemented by content that prioritizes sustainability, accessibility, and health outcomes over performance metrics.
The GLP-1 user represents a new archetype. They're motivated. They've made a significant commitment to improving their health, often at real financial cost. But their needs are specific: they need muscle preservation work, they need manageable intensity levels, and they need programming that fits into a life that already involves medical appointments, dietary adjustments, and metabolic monitoring.
Platforms that serve those needs earn long-term subscribers. Platforms that offer only high-intensity transformation programs risk losing this segment entirely, or worse, watching them exercise poorly and credit the medication rather than the fitness habit.
This also intersects with broader demographic trends. The audience most likely to be on GLP-1 medications overlaps substantially with the audience that fitness platforms have historically underserved: people over 45, those managing chronic conditions, and individuals who haven't identified as "gym people." Reaching them requires different language, different program formats, and explicit acknowledgment of where they're starting from.
If you're in that group, the habit-building research is genuinely encouraging. Getting stronger after 50 comes down to habits more than anything else, and short-format programming is one of the most effective ways to build those habits consistently.
What This Means for the Broader Fitness Market
BODi's catalog expansion is a data point in a larger trend. The fitness industry is watching GLP-1 adoption closely because the medications are reshaping what consumers need from exercise. Several key shifts are already visible:
- Strength training is becoming the default recommendation for weight-loss support rather than cardio. The emphasis has moved from burning calories to preserving lean mass.
- Session length expectations are dropping. Programs that once competed on volume are finding that accessibility and completion rates matter more to subscription retention than raw intensity.
- Medical-fitness integration is accelerating. Brands that can position their content as clinically complementary, rather than purely aspirational, gain credibility with a health-motivated consumer who is already engaged with the medical system.
- The longevity lens is replacing the transformation lens. Phrases like "burn fat fast" are giving way to language around metabolic health, functional aging, and long-term sustainability.
BODi's move is an early signal of what this repositioning looks like in practice. Whether it translates into subscriber growth depends on execution, but the strategic logic is sound.
Should You Try It?
If you're on a GLP-1 medication and looking for a structured way to add movement to your routine, a 10-minute daily program is a reasonable starting point. It's not going to replace comprehensive strength training as your fitness evolves, but it addresses the immediate priorities: building the habit, maintaining muscle activation, and keeping your body functional during a period of rapid physiological change.
The key is treating the short sessions as a foundation rather than a ceiling. As your energy stabilizes and the medication dose settles, adding volume gradually makes sense. The goal isn't to stay at 10 minutes forever. It's to not do nothing, which is the default for a lot of GLP-1 users who find conventional fitness content too demanding for where they are right now.
For anyone older who is managing these changes, the strength fundamentals don't shift based on medication status. Strength has become the defining fitness goal of 2026 for good reason, and preserving it while losing weight is the smartest thing you can do for your long-term health.
BODi's bet on GLP-1 support and short-format programming might look niche right now. Given the trajectory of weight-loss drug adoption, it's more likely to look prescient within a few years.